Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $41.9900 (-1.78%) ($41.9400 - $41.9900) on Wed. Aug. 23, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.03% (three month average) | RSI | 52 | Latest Price | $41.9900(-1.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.6% a day on average for past five trading days. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) SMH(82%) XBI(45%) IWO(35%) IWM(32%) IFRA(31%) | Factors Impacting HALO price | HALO will decline at least -1.015% in a week (0% probabilities). INDA(-34%) VXX(-23%) TBT(-21%) VIXM(-14%) OIH(-13%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.015% (StdDev 2.03%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $42.99 | 5 Day Moving Average | $42.64(-1.52%) | 10 Day Moving Average | $43.17(-2.73%) | 20 Day Moving Average | $42.99(-2.33%) | To recent high | -4.7% | To recent low | 29.5% | Market Cap | $5.739b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |